# SREBF1 Polymorphism and Egg Yolk on Cardiovascular Disease Risk in Healthy Young Adults: a Randomised, Two-period, Single Blinded, Crossover Trial

> **NCT04975048** · NA · SUSPENDED · sponsor: **Shandong University** · enrollment: 64 (actual)

## Conditions studied

- Healthy
- GEN1 Gene Mutation

## Interventions

- **DIETARY_SUPPLEMENT:** Egg yolks
- **DIETARY_SUPPLEMENT:** Macronutrients equivalent control

## Key facts

- **NCT ID:** NCT04975048
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-05-14
- **Primary completion:** 2020-01-12
- **Final completion:** 2025-12-01
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** Funding for secondary outcomes in fecal microbiome is not solved
- **Last updated:** 2025-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04975048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04975048, "SREBF1 Polymorphism and Egg Yolk on Cardiovascular Disease Risk in Healthy Young Adults: a Randomised, Two-period, Single Blinded, Crossover Trial". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04975048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*